Emergent Biosolutions(GB:0IGA)
$5.83+0.01 (+0.17%)
GB:0IGA
Emergent Biosolutions financials statements
$5.83
At close:+0.01 (+0.17%)
Emergent Biosolutions (0IGA) Income Statement
4 Followers
Emergent Biosolutions Income Statement
Last quarter (Q3 2026), Emergent Biosolutions's total revenue was $110.00M, a decrease of 52.40% from the same quarter last year. In Q3, Emergent Biosolutions's net income was $-32.70M. See Emergent Biosolutions’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 742.90M | $ 1.04B | $ 1.05B | $ 1.12B | $ 1.77B | |
| $ 350.60M | $ 375.40M | $ 360.00M | $ 473.00M | $ 793.20M | |
| $ 240.40M | $ 484.10M | $ 1.09B | $ 643.00M | $ 451.80M | |
| Depreciation and Amortization | $ 95.80M | $ 108.80M | $ 125.10M | $ 143.30M | $ 123.80M |
| $ 237.90M | $ 56.60M | $ -43.00M | $ 34.00M | $ 509.80M | |
| $ 110.20M | $ -108.70M | $ -726.40M | $ -170.00M | $ 341.40M | |
| $ -27.40M | $ -34.20M | $ -4.80M | $ -49.00M | $ -38.20M | |
| $ 82.80M | $ -142.90M | $ -731.20M | $ -219.00M | $ 303.20M | |
| $ 52.60M | $ -190.60M | $ -760.50M | $ -211.60M | $ 219.50M | |
| Per Share Metrics | |||||
| Basic EPS | $ 0.98 | $ -3.60 | $ -14.85 | $ -4.22 | $ 4.10 |
| Diluted EPS | $ 0.93 | $ -3.60 | $ -14.85 | $ -4.22 | $ 4.06 |
| Weighted Average Shares Outstanding | 53.50M | 53.00M | 51.20M | 50.10M | 53.50M |
| Weighted Average Shares Outstanding (Diluted) | 56.70M | 53.00M | 51.20M | 50.10M | 54.10M |
Currency in USD

